prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 264
2024
-
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status
Blood advances, year: 2024, volume: 10.1182/bl
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, DOI
2023
-
5′-UTR mRNA splicing determines CD20 levels
Year: 2023, type: Article in Periodical (without peer review)
-
Coculture model with CD40L, IL4 and IL21 for study chronic lymphocytic leukemia proliferation.
Year: 2023, type: Conference abstract
-
FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.
Year: 2023, type: Conference abstract
-
FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.
Year: 2023, type: Conference abstract
-
Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
-
Inhibitors for treatment of hematological malignancies
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11648255B2, year: 2023
-
Mechanismy adaptace CLL buněk na léčbu BCR inhibitory.
Year: 2023, type: Conference abstract
-
MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro
Stem Cell Reviews and Reports, year: 2023, volume: 19, edition: 5, DOI